Evidence map›Paper›PMID 27638841›Full record

ArticleCancer immunology research2016

Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice.

Hweixian Leong Penny, Tyler R Prestwood, Nupur Bhattacharya, Fionna Sun, Justin A Kenkel, Matthew G Davidson, Lei Shen, Luis A Zuniga, E Scott Seeley, Reetesh Pai and 5 more

Open access · greenAbstract read
In one paragraph

Article in Cancer immunology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cancers · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Retinoids as anti-cancer agents and their mechanisms of action.American journal of cancer research · 2022
    Review
  16. Retinoids as Chemo-Preventive and Molecular-Targeted Anti-Cancer Therapies.International journal of molecular sciences · 2021
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Hweixian Leong PennyDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California.
Tyler R PrestwoodDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California.
Nupur BhattacharyaDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California.
Fionna SunDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California.
Justin A KenkelDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California.
Matthew G DavidsonDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California.
Lei ShenDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California.
Luis A ZunigaDepartment of Immunology, Veterans Administration Hospital, Palo Alto, California.
E Scott SeeleyDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California.
Reetesh PaiDepartment of Pathology, Stanford University, Stanford, California.
Okmi ChoiDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California.
Lorna TolentinoDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California.
Jinshan WangDepartment of Nutritional Science and Toxicology, University of California, Berkeley, Berkeley, California.
Joseph L NapoliDepartment of Nutritional Science and Toxicology, University of California, Berkeley, Berkeley, California.
Edgar G EnglemanDepartment of Pathology, Stanford University School of Medicine (Blood Center), Palo Alto, California. edengleman@stanford.edu.
Stanford Blood Center · USUniversity of California, Berkeley · USStanford University · USUnited States Department of Veterans Affairs · US

Funding

TLI/ATG CONDTIONING: KIDNEY/BLOOD STEM CELL TRANSPLANTSP01HL075462 · NHLBI · STANFORD UNIVERSITY · PI ENGLEMAN, EDGAR G. · 2004 to 2020
$27.9M
MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse ModelU01CA141468 · NCI · STANFORD UNIVERSITY · PI ENGLEMAN, EDGAR G. · 2009 to 2013
$2.4M
Immunological Targeting of Colon Cancer Stem CellsF30CA196145 · NCI · STANFORD UNIVERSITY · PI PRESTWOOD, TYLER R. · 2015 to 2016
$71k
NCI NIH HHS F30 CA196145NCI NIH HHS U01 CA141468NHLBI NIH HHS P01 HL075462
6 · The paper itself

Abstract

Chronic intestinal inflammation accompanies familial adenomatous polyposis (FAP) and is a major risk factor for colorectal cancer in patients with this disease, but the cause of such inflammation is unknown. Because retinoic acid (RA) plays a critical role in maintaining immune homeostasis in the intestine, we hypothesized that altered RA metabolism contributes to inflammation and tumorigenesis in FAP. To assess this hypothesis, we analyzed RA metabolism in the intestines of patients with FAP as well as APC

Indexed as

Genes, APCAdenomaAdenomatous Polyposis ColiAnimalsAntineoplastic AgentsCell Transformation, NeoplasticColorectal NeoplasmsDendritic CellsEnterocolitisHumansMicePhenotypeTh17 CellsTretinoinTumor BurdenVitamin AAntineoplastic AgentsTretinoinVitamin A

Identifiers

PMID27638841
PMCPMC5378314
OpenAlexW2519582475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.